Skip to main content
iFHP Micro-Course: Introduction to Health Technology Assessment (HTA)
Location
Online
When
14th October 2026 13:30 – 16:45 UTC/GMT
Cost
£600 per person
Join our online micro-course on 16 April 2026 to explore how Health Technology Assessment (HTA) supports smarter decisions in pricing, coverage, and innovation.
Delivered in partnership with HAN University and UMC Utrecht, this interactive session is tailored for health insurance professionals worldwide.
Meeting Details

14th October 2026 13:30 – 16:45 UTC/GMT |  Online |  3 hour 15 mins Interactive Session

Join us for an intensive and interactive micro-course designed to introduce health insurance professionals to the fundamentals of Health Technology Assessment (HTA). This online session combines expert-led instruction, practical methodologies and real-world case study discussion to explain how HTA supports better decision-making in:

  • Determining Reimbursement Decisions
  • Negotiating Prices with Providers
  • Supporting Benefit Design
  • Ensuring Medical Necessity

Delivered in partnership with the HAN University of Applied Sciences and the University Medical Center, Utrecht, the micro-course draws on a decade of global HTA training experience and over 100 published evaluations.

What to Expect

A fast paced, interactive, online course with practical demonstration of how HTA informs evidence-based decisions in healthcare coverage, pricing and innovation.

During this course, you will gain a foundational understanding of Health Technology Assessment (HTA), including how it informs decision-making for both medicines and other healthcare technologies. You will also explore the roles and perspectives of the various stakeholders involved in the HTA process.

Through real-world examples and interactive breakout sessions, you will be introduced to key methodologies used in economic evaluations, helping to bridge theory with practical application.

Learning Objectives

By the end of this course, participants will be able to:

  • Define Health Technology Assessment and describe its purpose in healthcare.
  • Explain the role of HTA in the context of private health insurance.
  • Understand and interpret key HTA concepts, including cost-effectiveness, Quality Adjusted Life Years (QALYs), and the Incremental Cost-Effectiveness Ratio (ICER).
  • Describe how HTA findings influence coverage, reimbursement and pricing decisions.
  • Evaluate basic HTA case studies and apply insights to real-world decisions
  • Apply methodology of HTA on non-medication related innovations
Competencies Developed
  • Analytical Reasoning: Understanding evidence and interpreting cost-effectiveness data.
  • Health Economics Literacy: Covering core metrics like QALYs and ICERs.
  • Cross-Functional Awareness: Understanding inter-departmental collaboration on HTA.
  • Evidence-Based Decision Making: Applying HTA to coverage and contracting policies.
Who Should Attend

This course is designed for professionals involved in evaluating innovation and making effective resource allocation decisions within health insurance. It is particularly relevant for those working in the following areas:

  • Medical Affairs / Clinical Policy
  • Actuarial & Underwriting
  • Pharmacy & Therapeutics (P&T) Committees
  • Provider Contracting & Network Management
  • Data Analytics & Outcomes Research
  • Legal & Compliance
  • Product Development & Marketing
Preparation & Certification

Participants will be asked to complete 2 hours of self-directed preparation before the session.

Sign Up Now

Limited Spaces Available – Register Now!

For any enquiries, please contact Will@ifhp.com